Clinical Scorecard: The Impact of Gut Microbiome on Osteoporosis: Mechanisms, Clinical Links, and New Biomaterial Developments
At a Glance
Category
Detail
Condition
Key Mechanisms
Gut microbiota regulates bone homeostasis through microbial metabolite production (e.g., short-chain fatty acids), osteoimmune balance modulation, and regulation of nutrient absorption.
Target Population
Care Setting
Key Highlights
Clinical translation of gut microbiota-modulating therapies faces significant challenges due to individual microbial heterogeneity and biocompatibility risks.
Guideline-Based Recommendations
Diagnosis
Management
Consider pharmacological options including bisphosphonates, denosumab, and their mechanisms of action.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Older adults, particularly women post-menopause.
Current therapies are limited by adherence issues and adverse effects.
Clinical Best Practices
Integrate gut microbiome considerations into osteoporosis treatment strategies, focusing on personalized approaches.
As osteoporosis treatment continues to evolve, clinicians are moving beyond bone mineral density scores alone and placing greater emphasis on fracture risk when making therapeutic decisions
